MEDIBEN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIBEN
Largest movements
- Cash +€44,753
up €44,753 (+289%), from €15,475 to €60,228
mainly Net result for the year (+€47,304) and Receivables within one year (+€21,056)
- Receivables within one year -€21,056
down €21,056 (-46.5%), from €45,330 to €24,274
of which Other amounts receivable: -€24,068
- Other debts +€17,839
up €17,839 (+59.5%), from €30,000 to €47,839
- Tax, wage and social debts +€7,048
up €7,048 (+117%), from €6,030 to €13,078
of which Taxes: +€5,038
- Gross operating margin +€57,750
up €57,750 (+2,205%), from €2,619 to €60,369
- Taxes +€13,037
up €13,037 (+1,311%), from €994 to €14,031
- Financial charges -€1,148
down €1,148 (-73.4%), from €1,565 to €417
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €72,699 | €96,389 | +€23,690 | +32.6% |
| Current assets | 29/58 | €72,699 | €96,389 | +€23,690 | +32.6% |
| Amounts receivable within one year | 40/41 | €45,330 | €24,274 | -€21,056 | -46.5% |
| Trade receivables | 40 | - | €3,012 | +€3,012 | |
| Other amounts receivable | 41 | €45,330 | €21,262 | -€24,068 | -53.1% |
| Cash at bank and in hand | 54/58 | €15,475 | €60,228 | +€44,753 | +289% |
| Deferred charges and accrued income | 490/1 | €11,894 | €11,887 | -€7 | -0.1% |
| Total equity and liabilities | 10/49 | €72,699 | €96,389 | +€23,690 | +32.6% |
| Equity | 10/15 | €35,035 | €34,500 | -€535 | -1.5% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Reserves | 13 | €33,000 | €33,000 | = | 0.0% |
| Distributable reserves | 133 | €33,000 | €33,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €535 | - | -€535 | |
| Amounts payable | 17/49 | €37,664 | €61,889 | +€24,225 | +64.3% |
| Amounts payable within one year | 42/48 | €37,664 | €61,889 | +€24,225 | +64.3% |
| Trade debts | 44 | €1,634 | €973 | -€661 | -40.5% |
| Suppliers | 440/4 | €1,634 | €973 | -€661 | -40.5% |
| Taxes, remuneration and social security | 45 | €6,030 | €13,078 | +€7,048 | +117% |
| Taxes | 450/3 | €4,020 | €9,058 | +€5,038 | +125% |
| Remuneration and social security | 454/9 | €2,010 | €4,020 | +€2,010 | +100% |
| Other amounts payable | 47/48 | €30,000 | €47,839 | +€17,839 | +59.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €63 | - | -€63 | |
| Other operating charges | 640/8 | €506 | €481 | -€25 | -5.0% |
| Gross operating margin | 9900 | €2,619 | €60,369 | +€57,750 | +2,205% |
| Operating profit (loss) | 9901 | €2,050 | €59,888 | +€57,838 | +2,822% |
| Financial income | 75/76B | €1,841 | €1,864 | +€23 | +1.2% |
| Recurring financial income | 75 | €1,841 | €1,864 | +€23 | +1.2% |
| Financial charges | 65/66B | €1,565 | €417 | -€1,148 | -73.4% |
| Recurring financial charges | 65 | €1,565 | €417 | -€1,148 | -73.4% |
| Profit (loss) for the period before taxes | 9903 | €2,326 | €61,335 | +€59,009 | +2,537% |
| Income taxes | 67/77 | €994 | €14,031 | +€13,037 | +1,311% |
| Profit (loss) for the period | 9904 | €1,331 | €47,304 | +€45,972 | +3,453% |
| Profit (loss) for the period to be appropriated | 9905 | €1,331 | €47,304 | +€45,972 | +3,453% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.